| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) | Lancet, The | 1998 | 15.3K |
| Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness | Nurse Education Today | 2004 | 10K |
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) | Lancet, The | 1998 | 6.1K |
| Effects of intensive glucose lowering in type 2 diabetes | New England Journal of Medicine | 2008 | 5.8K |
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | New England Journal of Medicine | 2008 | 5.3K |
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 | | 1998 | 4.5K |
| Intensive insulin therapy in the medical ICU | New England Journal of Medicine | 2006 | 4.2K |
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Critical Care Medicine | 2004 | 4K |
| Intensive insulin therapy and pentastarch resuscitation in severe sepsis | New England Journal of Medicine | 2008 | 3.6K |
| Standards of medical care in diabetes--2014 | Diabetes Care | 2014 | 3.4K |
| Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Molecular and Cellular Biology | 1996 | 3.2K |
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Lancet, The | 2005 | 3.2K |
| Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetes Care | 2012 | 2.7K |
| Biology of incretins: GLP-1 and GIP | Gastroenterology | 2007 | 2.5K |
| Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes | Diabetes Care | 2009 | 2.4K |
| Glucose clamp technique: a method for quantifying insulin secretion and resistance | American Journal of Physiology - Endocrinology and Metabolism | 1979 | 2.4K |
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Diabetes Research and Clinical Practice | 1995 | 2.3K |
| Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy | New England Journal of Medicine | 2006 | 2.3K |
| Fetal nutrition and cardiovascular disease in adult life | Lancet, The | 1993 | 2.1K |
| Early versus late parenteral nutrition in critically ill adults | New England Journal of Medicine | 2011 | 2.1K |
| Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes | Diabetes Care | 2015 | 1.9K |
| Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study | Archives of Neurology | 1976 | 1.9K |
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Diabetes | 2009 | 1.8K |
| Endocrine regulation of energy metabolism by the skeleton | Cell | 2007 | 1.8K |
| Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control | Critical Care Medicine | 2003 | 1.8K |
